Found: 98
Select item for more details and to access through your institution.
Vemurafenib-induced progression of breast cancer: a case report and review of the literature.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Author Correction: Preclinical comparison of prolgolimab, pembrolizumab and nivolumab.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Preclinical comparison of prolgolimab, pembrolizumab and nivolumab.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72118-3
- By:
- Publication type:
- Article
Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2007, v. 133, n. 1, p. 57, doi. 10.1007/s00432-006-0146-0
- By:
- Publication type:
- Article
Combined CYP1A1/GSTM1 at-risk genotypes are overrepresented in squamous cell lung carcinoma patients but underrepresented in elderly tumor-free subjects.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2006, v. 132, n. 5, p. 327, doi. 10.1007/s00432-005-0071-7
- By:
- Publication type:
- Article
Hereditary Conditions Associated with Elevated Cancer Risk in Childhood.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 7, p. 880, doi. 10.1134/S0006297923070039
- By:
- Publication type:
- Article
First Two Cases of Bloom Syndrome in Russia: Lack of Skin Manifestations in a BLM c.1642C>T (p.Q548X) Homozygote as a Likely Cause of Underdiagnosis.
- Published in:
- Molecular Syndromology, 2017, v. 8, n. 2, p. 103, doi. 10.1159/000454820
- By:
- Publication type:
- Article
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.
- Published in:
- Hereditary Cancer in Clinical Practice, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s13053-021-00173-2
- By:
- Publication type:
- Article
Cytotoxic and targeted therapy for BRCA1/2-driven cancers.
- Published in:
- Hereditary Cancer in Clinical Practice, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s13053-021-00193-y
- By:
- Publication type:
- Article
Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine.
- Published in:
- Hereditary Cancer in Clinical Practice, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s13053-020-00157-8
- By:
- Publication type:
- Article
Cytotoxic and targeted therapy for hereditary cancers.
- Published in:
- Hereditary Cancer in Clinical Practice, 2016, v. 14, p. 1, doi. 10.1186/s13053-016-0057-2
- By:
- Publication type:
- Article
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4868, doi. 10.3390/ijms24054868
- By:
- Publication type:
- Article
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 1870, doi. 10.3390/ijms24031870
- By:
- Publication type:
- Article
Integrative Genomic Tests in Clinical Oncology.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13129, doi. 10.3390/ijms232113129
- By:
- Publication type:
- Article
Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4586, doi. 10.3390/ijms23094586
- By:
- Publication type:
- Article
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 10931, doi. 10.3390/ijms222010931
- By:
- Publication type:
- Article
A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 10, p. 5325, doi. 10.3390/ijms22105325
- By:
- Publication type:
- Article
Establishment and Long-Term Expansion of Small Cell Lung Cancer Patient-Derived Tumor Organoids.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1349, doi. 10.3390/ijms22031349
- By:
- Publication type:
- Article
Northern origin of the BRCA2 c.5286 T > G founder allele.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Northern origin of the BRCA2 c.5286 T > G founder allele.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 2, p. 283, doi. 10.1007/s10549-022-06517-3
- By:
- Publication type:
- Article
Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 184, n. 1, p. 229, doi. 10.1007/s10549-020-05827-8
- By:
- Publication type:
- Article
Aromatase, CYP1B1 and Fatty Acid Synthase Expression in Breast Tumors of BRCA1 Mutation Carriers.
- Published in:
- Pathology & Oncology Research, 2009, v. 15, n. 3, p. 407, doi. 10.1007/s12253-008-9137-6
- By:
- Publication type:
- Article
Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer.
- Published in:
- International Journal of Cancer, 1993, v. 53, n. 1, p. 11, doi. 10.1002/ijc.2910530104
- By:
- Publication type:
- Article
Mitomycin C plus cisplatin for systemic treatment of recurrent BRCA1-associated ovarian cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1872, doi. 10.1007/s10637-020-00965-8
- By:
- Publication type:
- Article
Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 894, doi. 10.1007/s10637-019-00842-z
- By:
- Publication type:
- Article
BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1136, doi. 10.1007/s10637-015-0280-0
- By:
- Publication type:
- Article
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 5, p. 850, doi. 10.1007/s10147-022-02128-6
- By:
- Publication type:
- Article
BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine.
- Published in:
- Scientific Reports, 2016, p. 28217, doi. 10.1038/srep28217
- By:
- Publication type:
- Article
Gene polymorphisms, apoptotic capacity and cancer risk.
- Published in:
- Human Genetics, 2009, v. 125, n. 3, p. 239, doi. 10.1007/s00439-009-0636-7
- By:
- Publication type:
- Article
Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 10, p. 605, doi. 10.1159/000449024
- By:
- Publication type:
- Article
Preclinical comparison of prolgolimab, pembrolizumab and nivolumab.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72118-3
- By:
- Publication type:
- Article
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.
- Published in:
- European Journal of Human Genetics, 2011, v. 19, n. 3, p. 300, doi. 10.1038/ejhg.2010.203
- By:
- Publication type:
- Article
Development of an interactive, agent-based local stochastic model of COVID-19 transmission and evaluation of mitigation strategies illustrated for the state of Massachusetts, USA.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0247182
- By:
- Publication type:
- Article
Evidence for a pathogenic role of BRCA1 L1705P and W1837X germ-line mutations.
- Published in:
- Molecular Biology Reports, 2016, v. 43, n. 5, p. 335, doi. 10.1007/s11033-016-3968-0
- By:
- Publication type:
- Article
Detection of BRCA1 gross rearrangements by droplet digital PCR.
- Published in:
- 2017
- By:
- Publication type:
- Report
The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Breast cancer sensitivity to neoadjuvant therapy in BRCA1 and CHEK2 mutation carriers and non-carriers.
- Published in:
- 2014
- By:
- Publication type:
- Report
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
- Published in:
- 2014
- By:
- Publication type:
- Report
High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas.
- Published in:
- 2012
- By:
- Publication type:
- Report
PALB2 mutations in German and Russian patients with bilateral breast cancer.
- Published in:
- 2011
- By:
- Publication type:
- Report
CHEK2 1100delC mutation is frequent among Russian breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2006, v. 100, n. 1, p. 99, doi. 10.1007/s10549-006-9227-7
- By:
- Publication type:
- Article
Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3167, doi. 10.1002/cam4.5159
- By:
- Publication type:
- Article
Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 17, p. 3226, doi. 10.1002/cam4.4686
- By:
- Publication type:
- Article
Agreement between PDL1 immunohistochemistry assays and polymerase chain reaction in non-small cell lung cancer: CLOVER comparison study.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60950-2
- By:
- Publication type:
- Article
Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.
- Published in:
- Oncogene, 1999, v. 18, n. 32, p. 4640, doi. 10.1038/sj.onc.1202863
- By:
- Publication type:
- Article
Hereditary Renal Cancer Syndromes.
- Published in:
- Medical Sciences, 2024, v. 12, n. 1, p. 12, doi. 10.3390/medsci12010012
- By:
- Publication type:
- Article
Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours.
- Published in:
- Histopathology, 2023, v. 83, n. 1, p. 109, doi. 10.1111/his.14912
- By:
- Publication type:
- Article
Searching for susceptibility alleles: Emphasis on bilateral breast cancer.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 4, p. 921, doi. 10.1002/ijc.22785
- By:
- Publication type:
- Article
Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 2, p. 297, doi. 10.1002/ijc.22265
- By:
- Publication type:
- Article